(Q45902882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Yiming Ma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Minghui Sun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Xuezhen Zhai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Zhaoze Fan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Rui Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Xiangliang Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

21 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

Drug Development and Industrial Pharmacy

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

986-994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21417621%20AND%20SRC:MED&resulttype=core&format=json

Sirolimus: its discovery, biological properties, and mechanism of action

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

The mammalian target of rapamycin signaling network and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

mTOR-targeted therapy of cancer with rapamycin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Interaction of immunosuppressive agents rapamycin and its analogue SDZ-RAD with endothelial P-gp

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Solubilization of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Preparation and evaluation of self-microemulsifying drug delivery system of oridonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

A refined method for sequential blood sampling by tail incision in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Enhancing intestinal drug solubilisation using lipid-based delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Lipid--an emerging platform for oral delivery of drugs with poor bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

P-glycoprotein and surfactants: effect on intestinal talinolol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618

Cleavage of the cyclohexyl-subunit of rapamycin results in loss of immunosuppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2011.553618